Please note that slides are for review only and not to be repurposed or published.

Part 1: Follicular Lymphoma (FL)

Introduction:
Dr Love

MODULE 1:
Optimizing the Care of Patients with Newly Diagnosed FL — Dr Fowler

MODULE 2:
Current Clinical Role of Maintenance Therapy in FL — Dr Zelenetz

MODULE 3:
Management of Relapsed/Refractory (R/R) FL; Novel Agents and Strategies Under Investigation — Dr Ansell

MODULE 4:
Treatment Strategies for Patients with Early Disease Relapse; Histologic Transformation of FL — Dr Sehn

Live Poll Results
Download

Part 2: Chronic Lymphocytic Leukemia (CLL)

Introduction:
Dr Love

MODULE 1:
Biomarker Assessment for Patients with CLL — Dr Davids

MODULE 2:
Biological and Clinical Considerations in the Treatment of Newly Diagnosed CLL — Prof Gribben

MODULE 3:
Contemporary Management of R/R CLL — Dr Friedberg

MODULE 4:
Novel Agents and Strategies Under Investigation in CLL — Dr Kipps

Live Poll Results
Download

Part 3: Mantle Cell Lymphoma (MCL)

Introduction:
Dr Love

MODULE 1:
Risk Stratification and Initial Management of Newly Diagnosed MCL — Dr Vose

MODULE 2:
Selection and Sequencing of Therapy for Patients with R/R MCL — Dr Leonard

MODULE 3:
FDA Approval of Acalabrutinib in R/R MCL and Integration into Clinical Treatment Algorithms — Dr Kahl

MODULE 4:
Emerging Research with and Ongoing Evaluation of Venetoclax and Other Novel Agents in R/R MCL — Dr Abramson

Live Poll Results
Download